Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Neuroscience ; 126(4): 1001-10, 2004.
Article in English | MEDLINE | ID: mdl-15207333

ABSTRACT

Voltage-gated K+ channels (Kv) are divided into eight subfamilies (Kv1-8) and play a major role in determining the excitability of neurones. Members of the Kv3 subfamily are highly abundant in the CNS, with each Kv3 gene (Kv3.1-Kv3.4) exhibiting a unique pattern of expression, although single neurones can express more than one subtype. Of the Kv3 subunits relatively little is known of the Kv3.4 subunit distribution in the nervous system, particularly in the brainstem and spinal cord of the rat. We performed immunohistochemistry to determine both the cellular and sub-cellular distribution of the Kv3.4 subunit in these areas. Kv3.4 subunit immunoreactivity (Kv3.4-IR) was widespread, with dense, punctate staining in many regions including the intermediolateral cell column (IML) and the dorsal vagal nucleus (DVN), nucleus ambiguus (NA) and nucleus tractus solitarius (NTS). In the ventral horn a presynaptic location was confirmed by co-localization of Kv3.4-IR with the synaptic vesicle protein, SV2 and also with the glutamate vesicle markers vesicular glutamate transporter (VGluT) 1, VGluT2 or the glycine transporter GlyT2, suggesting a role for the channel in both excitatory and inhibitory neurotransmission. Electron microscopy confirmed a presynaptic terminal location of Kv3.4-IR in the VH, IML, DVN, NA and NTS. Interestingly however, patches of Kv3.4-IR were also revealed postsynaptically in dendritic and somatic structures throughout these areas. This staining was striking due to its localization at synaptic junctions at terminals with morphological features consistent with excitatory functions, suggesting an association with the postsynaptic density. Therefore the pre and postsynaptic localization of Kv3.4-IR suggests a role both in the control of transmitter release and in regulating neuronal excitability.


Subject(s)
Brain Stem/metabolism , Dendrites/metabolism , Membrane Transport Proteins , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Presynaptic Terminals/metabolism , Spinal Cord/metabolism , Vesicular Transport Proteins , Amino Acid Transport Systems, Neutral/metabolism , Animals , Brain Stem/ultrastructure , Carrier Proteins/metabolism , Dendrites/ultrastructure , Glycine Plasma Membrane Transport Proteins , Humans , Immunohistochemistry/methods , Membrane Glycoproteins/metabolism , Microscopy, Immunoelectron/methods , Nerve Tissue Proteins/metabolism , Presynaptic Terminals/ultrastructure , Rats , Rats, Wistar , Shaw Potassium Channels , Spinal Cord/ultrastructure , Synapses/metabolism , Synapses/ultrastructure , Vesicular Glutamate Transport Protein 1 , Vesicular Glutamate Transport Protein 2
2.
J Neurosci ; 21(18): 7143-52, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11549725

ABSTRACT

The ionotropic ATP receptor subunits P2X(1-6) receptors play important roles in synaptic transmission, yet the P2X(7) receptor has been reported as absent from neurons in the normal adult brain. Here we use RT-PCR to demonstrate that transcripts for the P2X(7) receptor are present in extracts from the medulla oblongata, spinal cord, and nodose ganglion. Using in situ hybridization mRNA encoding, the P2X(7) receptor was detected in numerous neurons throughout the medulla oblongata and spinal cord. Localizing the P2X(7) receptor protein with immunohistochemistry and electron microscopy revealed that it is targeted to presynaptic terminals in the CNS. Anterograde labeling of vagal afferent terminals before immunohistochemistry confirmed the presence of the receptor in excitatory terminals. Pharmacological activation of the receptor in spinal cord slices by addition of 2'- and 3'-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP; 30 microm) resulted in glutamate mediated excitation of recorded neurons, blocked by P2X(7) receptor antagonists oxidized ATP (100 microm) and Brilliant Blue G (2 microm). At the neuromuscular junction (NMJ) immunohistochemistry revealed that the P2X(7) receptor was present in motor nerve terminals. Furthermore, motor nerve terminals loaded with the vital dye FM1-43 in isolated NMJ preparations destained after application of BzATP (30 microm). This BzATP evoked destaining is blocked by oxidized ATP (100 microm) and Brilliant Blue G (1 microm). This indicates that activation of the P2X(7) receptor promotes release of vesicular contents from presynaptic terminals. Such a widespread distribution and functional role suggests that the receptor may be involved in the fundamental regulation of synaptic transmission at the presynaptic site.


Subject(s)
Central Nervous System/metabolism , Neurons/metabolism , Peripheral Nervous System/metabolism , Presynaptic Terminals/metabolism , Receptors, Purinergic P2/metabolism , Animals , Central Nervous System/chemistry , Central Nervous System/cytology , Glutamic Acid/metabolism , Immunohistochemistry , In Situ Hybridization , Male , Medulla Oblongata/chemistry , Medulla Oblongata/cytology , Medulla Oblongata/metabolism , Mice , Mice, Inbred C57BL , Muscle, Skeletal/innervation , Neuromuscular Junction/metabolism , Neurons/cytology , Neurotransmitter Agents/metabolism , Nodose Ganglion/chemistry , Nodose Ganglion/cytology , Nodose Ganglion/metabolism , Patch-Clamp Techniques , Peripheral Nervous System/chemistry , Peripheral Nervous System/cytology , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X7 , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/chemistry , Spinal Cord/cytology , Spinal Cord/metabolism , Synaptic Transmission/physiology
3.
Neuroscience ; 106(2): 433-46, 2001.
Article in English | MEDLINE | ID: mdl-11566512

ABSTRACT

Sympathetic preganglionic neurones located in the intermediolateral cell column (IML) are subject to inputs descending from higher brain regions, as well as strong influences from local interneurones. Since interneurones in the IML have been rarely studied directly we examined their electrophysiological and anatomical properties. Whole cell patch clamp recordings were made from neurones in the IML of 250 microM slices of the thoracic spinal cord of the rat at room temperature. Action potential durations of interneurones (4.2+/-0.1 ms) were strikingly shorter than those of sympathetic preganglionic neurones (9.4+/-0.2 ms) due to a more rapid repolarisation phase. Low concentrations of tetraethylammonium chloride (TEA) (0.5 mM) or 4-aminopyridine (4-AP) (30 microM) affected interneurones but not sympathetic preganglionic neurones by prolonging the action potential repolarisation as well as decreasing both the afterhypolarisation amplitude and firing frequency. Following recordings, neurones sensitive to TEA and 4-AP were confirmed histologically as interneurones with axons that ramified extensively in the spinal cord, including the IML and other autonomic regions. In contrast, all cells that were insensitive to TEA and 4-AP were confirmed as sympathetic preganglionic neurones. Both electrophysiological and morphological data are therefore consistent with the presence of the voltage-gated potassium channel subunit Kv3.1 in interneurones, but not sympathetic preganglionic neurones. Testing this proposal immunohistochemically revealed that Kv3.1b was localised in low numbers of neurones within the IML but in higher numbers of neurones on the periphery of the IML. Kv3.1b-expressing neurones were not sympathetic preganglionic neurones since they were not retrogradely labelled following intraperitoneal injections of Fluorogold. Since Kv3.2 plays a similar role to Kv3.1 we also tested for the presence of Kv3.2 using immunohistochemistry, but failed to detect it in neuronal somata in the spinal cord. These studies provide electrophysiological and morphological data on interneurones in the IML and indicate that the channels containing the Kv3.1 subunit are important in setting the firing pattern of these neurones.


Subject(s)
Action Potentials/physiology , Interneurons/metabolism , Neuropeptides/metabolism , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Spinal Cord/metabolism , Stilbamidines , Sympathetic Nervous System/metabolism , 4-Aminopyridine/pharmacology , Action Potentials/drug effects , Animals , Axons/drug effects , Axons/metabolism , Axons/ultrastructure , Cell Size/physiology , Dendrites/drug effects , Dendrites/metabolism , Dendrites/ultrastructure , Fluorescent Dyes/pharmacokinetics , Immunohistochemistry , Interneurons/cytology , Interneurons/drug effects , Molecular Probes/pharmacokinetics , Neuropeptides/antagonists & inhibitors , Patch-Clamp Techniques , Potassium Channel Blockers , Rats , Shaw Potassium Channels , Spinal Cord/cytology , Spinal Cord/drug effects , Sympathetic Nervous System/cytology , Sympathetic Nervous System/drug effects , Tetraethylammonium/pharmacology , Thoracic Vertebrae
4.
J Neurosci ; 21(16): 6308-20, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11487654

ABSTRACT

Although adenosine is an important neuromodulator in the CNS, its role in modulating sympathetic outflow at the level of the spinal cord has not been studied. Because very little is known about adenosine A1 receptors (A1Rs) in the spinal cord, we determined their location and role with particular reference to the control of sympathetic preganglionic activity and interneuronal activity in the rat. High levels of immunoreactivity for A1Rs were observed throughout the spinal cord. Immunostaining was dense in the intermediolateral cell column (IML) and intercalated nucleus, regions containing retrogradely labeled sympathetic preganglionic neurons (SPNs). Electron microscopy revealed A1R immunoreactivity (A1R-IR) within presynaptic terminals and (to a lesser extent) postsynaptic structures in the IML, as well as the luminal membrane of endothelial cells lining capillaries. Using double-labeling techniques, some presynaptic terminals were observed to synapse onto SPNs. To investigate the effects of activating these A1Rs, visualized whole-cell patch-clamp recordings were made from electrophysiologically and morphologically identified SPNs and interneurons. Applications of the A1R agonist cyclopentyladenosine (CPA) reduced the amplitude of EPSPs elicited by stimulation of the lateral funiculus, an effect blocked by the A1R antagonist 8-cyclopentyl-1,3-dipropylxanthine. These effects were attributable to adenosine acting at a presynaptic site because CPA application increased the paired-pulse ratio. CPA did not affect evoked IPSPs. These data show that activating A1Rs reduces fast excitatory, but not inhibitory, transmission onto SPNs and interneurons in the IML and that A1Rs may play a protective role on neurons involved in the control of sympathetic outflow.


Subject(s)
Neural Inhibition/physiology , Receptors, Purinergic P1/metabolism , Sympathetic Nervous System/cytology , Sympathetic Nervous System/metabolism , Synapses/metabolism , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Antibody Specificity , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Immunohistochemistry , In Vitro Techniques , Interneurons/cytology , Interneurons/drug effects , Interneurons/metabolism , Male , Microscopy, Electron , Patch-Clamp Techniques , Purinergic P1 Receptor Agonists , Purinergic P1 Receptor Antagonists , Rats , Reaction Time/physiology , Spinal Cord/cytology , Spinal Cord/drug effects , Spinal Cord/metabolism , Sympathetic Nervous System/drug effects , Synapses/ultrastructure , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Thorax , Xanthines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...